Moderna COVID-19
Vaccine, Bivalent
is now authorized
The updated booster from Moderna is designed to help protect against multiple COVID-19 variants in a single shot.

Overview for Vaccine Recipients


Initial Adult Vaccination
Looking for information on adult primary series vaccination?
Visit spikevax(COVID‑19 vaccine, mRNA)
Bivalent Booster Dose
The Moderna COVID-19 Vaccine, Bivalent has received emergency use authorization from the FDA to provide individuals 6 years of age and older a single booster dose administered at least 2 months after:
- Completion of primary vaccination with any authorized or approved monovalent COVID-19 vaccine
- Receipt of the most recent booster dose with any authorized or approved monovalent COVID-19 vaccine



What are the Moderna COVID‑19 Vaccines?
In five clinical trials, approximately 40,000 participants aged 6 months and older received at least one dose of Moderna COVID-19 Vaccine.
Learn more about the vaccineWhat Do We Know About the Safety of the Vaccines?
In five clinical trials, approximately 40,000 participants aged 6 months and older received at least one dose of Moderna COVID‑19 Vaccine.
See what is known about vaccine safetyFrequently Asked
Questions
Do you have more questions about the vaccines? Take a look at our answers to the questions we hear most often.
About Moderna
1‑866‑MODERNA (1‑866‑663‑3762)
8:00AM - 8:00PM EST, Monday-Friday (not including Holidays)
MedInfo@modernatx.com